RAPT Therapeutics Announces $150 Million Private Placement

Stock Information for RAPT Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About RAPT Therapeutics Inc.

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody
RAPT Therapeutics Reports Third Quarter 2024 Financial Results
Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.